PITPNA
Phosphatidylinositol transfer protein alpha isoform
Also known as: PIPNA_HUMAN, PITPN, VIB1A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q00169
- Gene
- PITPNA
- Ensembl
- ENSG00000174238
- Chromosome
- 17
- Canonical length
- 270 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a member of a family of lipid-binding proteins that transfer molecules of phosphatidylinositol or phosphatidylcholine between membrane surfaces. The protein is implicated in phospholipase C signaling and in the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3) by phosphoinositide-3-kinase.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
270 residues, UniProt reviewed canonical sequence.
>Q00169|PITPNA
1 MVLLKEYRVI LPVSVDEYQV GQLYSVAEAS KNETGGGEGV EVLVNEPYEK DGEKGQYTHK
61 IYHLQSKVPT FVRMLAPEGA LNIHEKAWNA YPYCRTVITN EYMKEDFLIK IETWHKPDLG
121 TQENVHKLEP EAWKHVEAVY IDIADRSQVL SKDYKAEEDP AKFKSIKTGR GPLGPNWKQE
181 LVNQKDCPYM CAYKLVTVKF KWWGLQNKVE NFIHKQERRL FTNFHRQLFC WLDKWVDLTM
241 DDIRRMEEET KRQLDEMRQK DPVKGMTADDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PITPNA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 85 nTPM
- skin: 82 nTPM
- salivary gland: 79 nTPM
- small intestine: 77 nTPM
- esophagus: 67 nTPM
- cerebral cortex: 63 nTPM
Single-cell type
- retinal pigment epithelial cells: 1,334 nCPM
- neutrophils: 766 nCPM
- syncytiotrophoblasts: 382 nCPM
- decidual stromal cells: 256 nCPM
- monocytes: 252 nCPM
- suprabasal keratinocytes: 191 nCPM
Immune cell
- neutrophil: 7.6 nTPM
- T-reg: 5.3 nTPM
- memory B-cell: 4.3 nTPM
- MAIT T-cell: 4 nTPM
- basophil: 3.8 nTPM
- NK-cell: 3.8 nTPM
Brain region
- pons: 112 nTPM
- cerebral cortex: 97 nTPM
- thalamus: 94 nTPM
- choroid plexus: 93 nTPM
- medulla oblongata: 93 nTPM
- hypothalamus: 91 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.44
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- lipid binding
- phosphatidylcholine binding
- phosphatidylcholine transfer activity
- phosphatidylcholine transporter activity
- phosphatidylglycerol binding
- phosphatidylinositol binding
- phosphatidylinositol transfer activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PITPNA as an antibody target. Whether an autoantibody or antibody against PITPNA could matter depends on whether native PITPNA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PITPNA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PITPNA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...